» Articles » PMID: 26173246

Your Brain on Insulin: From Heresy to Dogma

Overview
Specialty Psychology
Date 2015 Jul 15
PMID 26173246
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

As recently as 1988, the idea that insulin might regulate cognitive and neural functions was, if not quite heretical, still seen as unlikely. As our ability to measure metabolic and molecular changes in the brain has improved, the hippocampus in particular has been revealed as a primary target for insulin. Today insulin is established as a key regulator of hippocampal fuel supply and a critical component of memory formation and storage within the hippocampus. Brain insulin signaling is a target for therapeutic intervention in patients with neuropsychological conditions such as Alzheimer's disease.

Citing Articles

Breakdown of the blood-brain barrier: A mediator of increased Alzheimer's risk in patients with metabolic disorders?.

Frank C, McNay E J Neuroendocrinol. 2021; 34(1):e13074.

PMID: 34904299 PMC: 8791015. DOI: 10.1111/jne.13074.

References
1.
Benedict C, Hallschmid M, Hatke A, Schultes B, Fehm H, Born J . Intranasal insulin improves memory in humans. Psychoneuroendocrinology. 2004; 29(10):1326-34. DOI: 10.1016/j.psyneuen.2004.04.003. View

2.
McNay E, Recknagel A . Brain insulin signaling: a key component of cognitive processes and a potential basis for cognitive impairment in type 2 diabetes. Neurobiol Learn Mem. 2011; 96(3):432-42. PMC: 3190063. DOI: 10.1016/j.nlm.2011.08.005. View

3.
Biessels G, Kappelle A, Bravenboer B, Erkelens D, Gispen W . Cerebral function in diabetes mellitus. Diabetologia. 1994; 37(7):643-50. DOI: 10.1007/BF00417687. View

4.
Woods S, Porte Jr D, Bobbioni E, Ionescu E, Sauter J, Rohner-Jeanrenaud F . Insulin: its relationship to the central nervous system and to the control of food intake and body weight. Am J Clin Nutr. 1985; 42(5 Suppl):1063-71. DOI: 10.1093/ajcn/42.5.1063. View

5.
Watson G, Cholerton B, Reger M, Baker L, Plymate S, Asthana S . Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. Am J Geriatr Psychiatry. 2005; 13(11):950-8. DOI: 10.1176/appi.ajgp.13.11.950. View